CSIMarket
 
Vycor Medical Inc   (VYCO)
Other Ticker:  
 
 
Price: $0.0840 $-0.01 -5.618%
Day's High: $0.084 Week Perf: -9.68 %
Day's Low: $ 0.08 30 Day Perf: -5.62 %
Volume (M): 1 52 Wk High: $ 0.10
Volume (M$): $ 0 52 Wk Avg: $0.08
Open: $0.08 52 Wk Low: $0.04



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 37
 Employees -
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Vycor Medical Inc
Vycor Medical Inc is a medical device company that specializes in developing, manufacturing, and selling innovative neurosurgical and neurotherapeutic solutions. The company focuses on providing advanced tools and technologies that improve surgical outcomes and enhance patient quality of life.

Vycor Medical's flagship product is the ViewSite Brain Access System, which offers surgeons a minimally invasive approach to brain surgery. This system allows for better visualization and access to the surgical field, leading to improved accuracy and reduced risk for patients. The company also offers other specialized surgical instrumentation and devices that aid in neurosurgical procedures.

In addition to surgical tools, Vycor Medical is actively involved in developing therapeutic solutions for neurological conditions such as traumatic brain injuries and neurodegenerative diseases. The company aims to leverage its expertise to develop innovative treatments that improve patient outcomes and address unmet medical needs in the field of neurology.

Overall, Vycor Medical Inc is committed to advancing the field of neurosurgery and neurology through its cutting-edge products and therapies, with a focus on enhancing patient care and improving surgical outcomes.


   Company Address: 951 Broken Sound Parkway Boca Raton 33487 FL
   Company Phone Number: 558-2020   Stock Exchange / Ticker: VYCO
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Vycor Medical Inc

Vycor Medical Inc Shines Bright with a Whopping 47% Revenue Growth in Q2 2023

Vycor Medical Inc, a leading Medical Equipment & Supplies company, has reported its earnings for the second quarter of 2023. While the company achieved zero gain per share, this is consistent with the previous year's result and the previous financial reporting period. However, it is important to note the significant improvement in revenue, which increased by 47.22% to $0.48 million compared to the same period last year. Sequentially, revenue grew by 33.733% from $0.36 million.
The substantial growth in revenue sets Vycor Medical Inc apart from its industry contemporaries, as the Medical Equipment & Supplies industry experienced an overall revenue elevation of only 3.90% during the same period. This emphasizes the strong performance of the company in comparison to its competitors.

Vycor Medical Inc

Vycor Medical Inc Struggles to Stay Afloat Despite Impressive Revenue Growth

Investors in Vycor Medical Inc should brace for tough times ahead as the company seems to be in a precarious spot in terms of its financials. Despite impressive revenue growth of 15.027% to $0.36 million between January and March 2023, Vycor Medical Inc failed to grow its income. The income stayed unchanged at $0.00 per share, year on year. This is a worrying sign as it shows that the company's operations are not generating enough revenue to cover its expenses and eventually, create profits for shareholders.
The revenue growth recorded by Vycor Medical Inc in the first quarter of the year was commendable, but that alone does not guarantee the success of the company. The fact that the income remained stagnant implies that the company is either experiencing cost overruns or facing competitive pricing pressure that is eroding its margins. Either way, this is not a good sign for investors who expect to see their investment grow in value over time.






 

Vycor Medical Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com